**Core Concept**
Hamman-Rich syndrome, also known as acute interstitial pneumonia (AIP), is a rare and severe form of lung injury characterized by diffuse alveolar damage, leading to impaired gas exchange and potentially life-threatening respiratory failure.

**Why the Correct Answer is Right**
Hamman-Rich syndrome is a form of acute respiratory distress syndrome (ARDS), which is a complex condition involving inflammation, coagulation, and disruption of the alveolar-capillary membrane. The correct treatment approach involves addressing the underlying cause, if possible, and providing supportive care to manage symptoms and prevent complications. Corticosteroids have been shown to reduce mortality in patients with Hamman-Rich syndrome by modulating the inflammatory response and improving lung function.

**Why Each Wrong Option is Incorrect**
**Option A:** Supportive care alone is insufficient to manage the severe inflammation and lung damage associated with Hamman-Rich syndrome.
**Option B:** Antibiotics are not effective in treating Hamman-Rich syndrome, as the condition is not primarily caused by a bacterial infection.
**Option C:** Lung transplantation may be considered in severe cases, but it is not a first-line treatment for Hamman-Rich syndrome.

**Clinical Pearl / High-Yield Fact**
Be aware of the key differences between Hamman-Rich syndrome (ARDS) and other forms of lung injury, such as chronic obstructive pulmonary disease (COPD) or pulmonary embolism, to ensure accurate diagnosis and treatment.

**Correct Answer:** C. Corticosteroids. Corticosteroids are the best treatment option for Hamman-Rich syndrome.